​
Login / Signup
Jaspreet Kaur
ORCID
Publication Activity (10 Years)
Years Active: 2020-2022
Publications (10 Years): 6
Top Topics
Adverse Drug
Living Cells
Multiple Myeloma
Uric Acid
Top Venues
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shahaf Tuler
,
Jaspreet Kaur
,
Constantin A Dasanu
Cecal volvulus associated with carfilzomib use for al amyloidosis.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(2022)
Arsia Jamali
,
Khashayar Nemovi
,
Jaspreet Kaur
,
Constantin A Dasanu
Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(2022)
Jaspreet Kaur
,
Shahaf Tuler
,
Constantin A Dasanu
Sustained erythrocytosis due to the use of Lenvatinib.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(2021)
Jaspreet Kaur
,
Shahaf Tuler
,
Constantin A Dasanu
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
27 (7) (2021)
Jaspreet Kaur
,
Shahaf Tuler
,
Constantin A Dasanu
Acute gout flare of bilateral first metatarsophalangeal joints due to ibrutinib use in chronic lymphocytic leukemia.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(2021)
Shahaf Tuler
,
Jaspreet Kaur
,
Suzette Delaware
,
Constantin A Dasanu
Multidirectional pattern of hair growth with carflizomib use for multiple myeloma.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
27 (5) (2020)